Impact of micro- and macronutrient status on the incidence of tuberculosis: An examination of an African cohort initiating antiretroviral therapy.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2023
Historique:
received: 16 03 2023
accepted: 23 05 2023
medline: 13 7 2023
pubmed: 13 7 2023
entrez: 13 7 2023
Statut: epublish

Résumé

Macronutrient and micronutrient deficiencies are associated with tuberculosis (TB) incidence. However, evidence is limited on the impact of micronutrient (vitamins and minerals) supplementation among underweight individuals. We conducted a secondary data analysis of a randomised controlled trial of lipid nutritional supplements with and without high-dose vitamin and mineral supplementation (LNS-VM vs LNS) for underweight (Body Mass Index [BMI] <18.5 kg/m2) adults with human immunodeficiency virus (HIV) initiating antiretroviral therapy (ART) in Tanzania and Zambia (2011-2013). Incident TB disease diagnoses were extracted from trial records. We used multivariable Cox regression to estimate hazard ratios (HR) for the impact of receiving LNS-VM on TB incidence, and the dose-response relationship between baseline BMI and TB incidence. Overall, 263 (17%) of 1506 participants developed TB disease. After adjusting for age, sex, CD4 count, haemoglobin, and C-reactive protein, receiving LNS-VM was not associated with TB incidence (aHR [95%CI] = 0.93 [0.72-1.20]; p = 0.57) compared to LNS alone. There was strong evidence for an association between lower BMI and incident TB (aHR [95%CI]: 16-16.9kg/m2 = 1.15 [0.82-1.62] and <16kg/m2 = 1.70 [1.26-2.30] compared to 17-18.5kg/m2; linear trend p<0.01). There was strong evidence that the rate of developing TB was lower after initiating ART (p<0.01). In conclusion, the addition of micronutrient supplementation to LNS was not associated with lower TB incidence in this underweight ART-naive population.

Identifiants

pubmed: 37440476
doi: 10.1371/journal.pgph.0002007
pii: PGPH-D-23-00440
pmc: PMC10343057
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0002007

Informations de copyright

Copyright: © 2023 Schwalb et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Thorax. 2017 Jun;72(6):559-575
pubmed: 28115682
Int J Epidemiol. 2010 Feb;39(1):149-55
pubmed: 19820104
Int J STD AIDS. 2005 Feb;16(2):95-100; quiz 101
pubmed: 15807935
Trans R Soc Trop Med Hyg. 2002 May-Jun;96(3):291-4
pubmed: 12174782
J Int AIDS Soc. 2022 Apr;25(4):e25900
pubmed: 35384317
BMJ Open. 2022 Mar 16;12(3):e050928
pubmed: 35296472
J Nutr. 2018 Jan 1;148(1):56-62
pubmed: 29378042
Lung India. 2009 Jan;26(1):9-16
pubmed: 20165588
Int J Tuberc Lung Dis. 2011 Jul;15(7):871-85
pubmed: 21496360
Drug Des Devel Ther. 2016 Dec 28;11:91-102
pubmed: 28096657
BMC Med. 2015 Jan 28;13:17
pubmed: 25630368
Am J Respir Crit Care Med. 2012 Sep 1;186(5):442-9
pubmed: 22773730
J Trace Elem Med Biol. 2018 Dec;50:257-262
pubmed: 30262288
J Nutr. 2003 May;133(5 Suppl 2):1649S-1655S
pubmed: 12730480
Nutr Rev. 2003 Mar;61(3):81-90
pubmed: 12723640
Lancet HIV. 2020 Jul;7(7):e463-e471
pubmed: 32621874
Sci Rep. 2022 Sep 28;12(1):16207
pubmed: 36171396
Nutr Diet Suppl. 2017;2017(9):37-45
pubmed: 29187783
Br J Hosp Med. 1996 Sep 4-17;56(5):200-4
pubmed: 8879697
Clin Dev Immunol. 2012;2012:784740
pubmed: 22242039
Lancet Infect Dis. 2020 Jan;20(1):110-122
pubmed: 31678031
Clin Infect Dis. 2017 Sep 15;65(6):900-909
pubmed: 28531276
Food Nutr Bull. 2010 Dec;31(4):S345-64
pubmed: 21214037
Cochrane Database Syst Rev. 2016 Jun 29;(6):CD006086
pubmed: 27355911
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Clin Infect Dis. 2010 May 15;50 Suppl 3:S67-70
pubmed: 20397958
PLoS Med. 2012;9(7):e1001270
pubmed: 22911011
Clin Infect Dis. 2010 May 15;50 Suppl 3:S223-30
pubmed: 20397952
Int J Tuberc Lung Dis. 2004 Mar;8(3):286-98
pubmed: 15139466

Auteurs

Alvaro Schwalb (A)

Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.

Malin Bergstrom (M)

Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Susannah Woodd (S)

Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Andrea M Rehman (AM)

Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.

George PrayGod (G)

Mwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania.

Lackson Kasonka (L)

University Teaching Hospital, Lusaka, Zambia.

John R Koethe (JR)

Vanderbilt Institute of Global Health, Vanderbilt University School of Medicine, Nashville, TN, United States of America.

Suzanne Filteau (S)

Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Rein M G J Houben (RMGJ)

Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Classifications MeSH